Bellotti G, de Moraes A V, Bocchi E A, Graziozi P, Medeiros C C, Cerri G, Stolf N, Jatene A, Pileggi F
Instituto do Coracão do Hospital das Clínicas-FMUSP, São Paulo.
Arq Bras Cardiol. 1996 Jul;67(1):5-9.
To test the hypothesis that rejection could affect the contractility and contractile reserve of left ventricle after heart transplantation.
Echocardiographic parameters and noninvasive blood pressure end-systolic pressure (ESP), heart rate (HR), end diastolic (EDV) and end-systolic (ESV) volumes, ejection fraction (EF), end-systolic stress (ESS) and the end-systolic relation (ESS/ESV) were recorded in 68 studies in 11 patients, seven days-12 months after heart transplantation. Accordingly with the endomyocardial biopsies results were divided into two groups: group A-with no rejection (53 studies), and group B-with rejection (15 studies).
The nitroprusside infusion changed significantly and in the same way, all the parameters except the ESS/ESV ratio (A = 5.5 +/- 1.7 x B = 4.8 +/- 1.5 g/cm2/mL, p = NS); there was a decrease in ESP (A = 107 +/- 15 and B = 109 +/- 12 mmHg, p = NS), EDV (A = 68 +/- 19 and B = 81 +/- 12 mL, p = NS), ESV (A = 12 +/- 5 and B = 18 +/- 12 mL, p = NS) and ESS (A = 59 +/- 13 and B = 82 +/- 20g/cm2, p = NS); there was an increase in HR (A = 94 +/- 9 and B = 93 +/- 16bpm, p = NS) and EF (A = 83 +/- 5 and B = 79 +/- 8%, p = NS). In the dobutamine study it was observed differences for both groups, except for ESP (A = 156 +/- 26 and B = 149 +/- 26mmHg, p = NS). The increase in HR, EF and ESS/ESV ratio was greater in group A (HR-A = 117 +/- 19 and B = 102 +/- 25bpm, p < 0.05; EF-A = 91 +/- 4 and B = 78 +/- 11%, p < 0.05; ESS/ESV-A = 13.1 +/- 6 and B = 6.1 +/- 3.1 g/cm2/mL, p < 0.05). For group A it was smaller the EDV (57 +/- 18 x 94 +/- 35 mL, p < 0.05), ESV (5 +/- 3 x 24 +/- 20 mL, p < 0.05) and ESS (57 +/- 21 x 102 +/- 40 g/cm2, p < 0.05).
Rejection may not induce changes in resting left ventricular contractility, however, the contractile reserve is depressed during an episode of moderate to severe rejection.
验证心脏移植后排斥反应是否会影响左心室的收缩力和收缩储备这一假设。
对11例患者进行了68次研究,在心脏移植后7天至12个月期间,记录超声心动图参数以及无创血压的收缩末期压力(ESP)、心率(HR)、舒张末期容积(EDV)、收缩末期容积(ESV)、射血分数(EF)、收缩末期应力(ESS)和收缩末期关系(ESS/ESV)。根据心内膜活检结果将患者分为两组:A组——无排斥反应(53次研究),B组——有排斥反应(15次研究)。
静脉输注硝普钠后,除ESS/ESV比值外(A组 = 5.5 ± 1.7 对比 B组 = 4.8 ± 1.5 g/cm²/mL,p值无统计学意义),所有参数均有显著且相同方式的变化;ESP降低(A组 = 107 ± 15 对比 B组 = 109 ± 12 mmHg,p值无统计学意义),EDV降低(A组 = 68 ± 19 对比 B组 = 81 ± 12 mL,p值无统计学意义),ESV降低(A组 = 12 ± 5 对比 B组 = 18 ± 12 mL,p值无统计学意义),ESS降低(A组 = 59 ± 13 对比 B组 = 82 ± 20 g/cm²,p值无统计学意义);HR升高(A组 = 94 ± 9 对比 B组 = 93 ± 16 bpm,p值无统计学意义),EF升高(A组 = 83 ± 5 对比 B组 = 79 ± 8%,p值无统计学意义)。在多巴酚丁胺研究中,观察到两组存在差异,但ESP除外(A组 = 156 ± 26 对比 B组 = 149 ± 26 mmHg,p值无统计学意义)。A组HR、EF和ESS/ESV比值的升高幅度更大(HR - A组 = 117 ± 19 对比 B组 = 102 ± 25 bpm,p < 0.05;EF - A组 = 91 ± 4 对比 B组 = 78 ± 11%,p < 0.05;ESS/ESV - A组 = 13.1 ± 6 对比 B组 = 6.1 ± 3.1 g/cm²/mL,p < 0.05)。A组的EDV(57 ± 18 对比 94 ± 35 mL,p < 0.05)、ESV(5 ± 3 对比 24 ± 20 mL,p < 0.05)和ESS(57 ± 21 对比 102 ± 40 g/cm²,p < 0.05)较小。
排斥反应可能不会引起静息状态下左心室收缩力的变化,然而,在中度至重度排斥反应发作期间,收缩储备会降低。